	Ebitda		Date
Abbott	USD 3.09B	44M	2025-09
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
Akebia Therapeutics	USD 14.03M	17.19M	2025-03
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
AstraZeneca	USD 5.23B	272M	2025-09
BioMarin Pharmaceutical	USD -24.17M	18.91M	2025-12
Coherus Biosciences	USD -44.34M	9.82M	2025-03
Eli Lilly	USD 7.88B	378.1M	2025-09
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Illumina	USD 332M	12M	2025-09
Insmed	USD -314.19M	31.48M	2025-12
Ironwood Pharmaceuticals	USD 81.81M	31.71M	2025-09
J&J	USD 9.52B	389M	2025-09
MacroGenics	USD 21.95M	55.39M	2025-09
MannKind	USD 17.92M	8.17M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Moderna	USD -790M	582M	2025-12
Novartis	USD 5.88B	290M	2025-09
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Thermo Fisher Scientific	USD 3.17B	335M	2025-12
Ultragenyx Pharmaceutical	USD -156.79M	65.44M	2025-09
United Therapeutics	USD 379.5M	83.4M	2025-12
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12

Lexicon Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.